Inspire Medical Systems (STU:2DR) Market Cap: €1,159.5 Mil (As of Jun. 29, 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
59 GF Score
Price €40.00
GF Value €190.55
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Market Cap?

Inspire Medical Systems STU:2DR +4.17% 59 Market Cap is €1,159.5 Mil as of Jun. 29, 2026. GuruFocus rates STU:2DR with a GF Score™ of 59/100 and a GF Value™ of €190.55 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Inspire Medical Systems ranks better than 83.06% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Inspire Medical Systems's share price for the quarter that ended in Mar. 2026 was €44.28. Inspire Medical Systems's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 28.8 Mil. Therefore, Inspire Medical Systems's market cap for the quarter that ended in Mar. 2026 was €1,275.4 Mil.

Inspire Medical Systems's quarterly market cap increased from Sep. 2025 (€1,844.3 Mil) to Dec. 2025 (€2,237.2 Mil) but then declined from Dec. 2025 (€2,237.2 Mil) to Mar. 2026 (€1,275.4 Mil).

Inspire Medical Systems's annual market cap declined from Dec. 2023 (€5,409.5 Mil) to Dec. 2024 (€5,278.9 Mil) and declined from Dec. 2024 (€5,278.9 Mil) to Dec. 2025 (€2,237.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Inspire Medical Systems's Enterprise Value for Today is €935.7 Mil.


Inspire Medical Systems  (STU:2DR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Inspire Medical Systems Market Cap Related Terms


Inspire Medical Systems Market Cap Historical Data

* Premium members only.

The historical data trend for Inspire Medical Systems's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems Market Cap Chart

Inspire Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,466.75 6,819.78 5,409.48 5,278.85 2,237.16

Inspire Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,306.60 3,249.63 1,844.28 2,237.16 1,275.35

STU:2DR vs ENOV, PRCT, AHCO: Market Cap Comparison

For the Medical Devices subindustry, Inspire Medical Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Market Cap distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Market Cap falls into.


STU:2DR
59GF Score
Inspire Medical Systems Inc STU:2DR
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Inspire Medical Systems's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€78.28*28.579
=€2,237.2

Inspire Medical Systems's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€44.28*28.802
=€1,275.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €1,159.5 Mil mean?
Inspire Medical Systems (STU:2DR) has a Market Cap of €1,159.5 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #147 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 16.9%.
Is Inspire Medical Systems' Market Cap too high?
Inspire Medical Systems' current Market Cap is €1,159.5 Mil. Based on the distribution chart, Inspire Medical Systems ranks #147 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Market Cap compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #147 out of 868 companies for Market Cap. This places Inspire Medical Systems in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 118.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current Market Cap is €1,159.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €190.55, compared to a current price of €40.00 — trading 79% below its estimated fair value. The current Market Cap is €1,159.5 Mil. Inspire Medical Systems' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Market Cap is €1,159.5 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €40.00 is trading 79% below its estimated GF Value™ of €190.55. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Market Cap: €1,159.5 Mil
  • GF Value™: €190.55 vs. price of €40.00 (79% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
59GF Score

Get the complete analysis for STU:2DR

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.00
Price
€190.55
GF Value